CAMP vs CBRE · rev $652.0K vs P/E 43, rev $35.77B
CAMP4 THERAPEUTICS CORPORATION (CAMP) versus CBRE Group Inc Class A (CBRE) — a side-by-side from cached financials, not a winner call.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Latest reported CAMP revenue for 2024-12-31 was $652.0K. Net income was -$51.8M. Revenue was up 86.3% from 2023-12-31 to 2024-12-31. CAMP currently screens at market cap $215.0M.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
CAMP currently screens at market cap $215.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Not investment advice. Open the CAMP and CBRE stock pages for the full models.
Not investment advice.